News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Factor Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
News
Last Orders: ASX ends 5 day winning streak but still above 7,000
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Factor Therapeutics back to square one after proposed vet imaging deal falls over
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Health & Biotech
Check up: Maybe next week will be better?
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
RAMCap wants to turn Factor Therapeutics into a hedge fund business
Health & Biotech
Check up: The COVID-crisis strikes leaving just 9 stocks in the black
Health & Biotech
My bank balance is bigger than yours: biotech quarterlies
Health & Biotech
9 of the most interesting biotech bosses in the game today: part 1
News
Corporate: Factor Therapeutics still looking for its next opportunity
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
Health & Biotech
Health: Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer
News
Corporate: Oilex wants to put its legal ruckus with Indian partner to bed
News
